These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34645996)

  • 1. 'I hope you die': how the COVID pandemic unleashed attacks on scientists.
    Nogrady B
    Nature; 2021 Oct; 598(7880):250-253. PubMed ID: 34645996
    [No Abstract]   [Full Text] [Related]  

  • 2. When SARS-CoV-2 comes knocking on your lab door: Individual scientists' experiences during the pandemic.
    Wolinsky H
    EMBO Rep; 2020 Jul; 21(7):e50946. PubMed ID: 32537839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID scientists in the public eye need protection from threats.
    Nature; 2021 Oct; 598(7880):236. PubMed ID: 34646005
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
    Frigerio M
    Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
    [No Abstract]   [Full Text] [Related]  

  • 5. Moving a research lab during the COVID-19 pandemic.
    Casadio M; Simon D
    J Cell Biol; 2021 Jan; 220(1):. PubMed ID: 33332553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
    Arshad S; Kilgore P; Chaudhry ZS; Jacobsen G; Wang DD; Huitsing K; Brar I; Alangaden GJ; Ramesh MS; McKinnon JE; O'Neill W; Zervos M;
    Int J Infect Dis; 2020 Aug; 97():396-403. PubMed ID: 32623082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.
    Siddiqui AJ; Jahan S; Ashraf SA; Alreshidi M; Ashraf MS; Patel M; Snoussi M; Singh R; Adnan M
    J Biomol Struct Dyn; 2021 Oct; 39(17):6828-6841. PubMed ID: 32752944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient prescription patterns of COVID-19 drugs in the metropolitan area of Mexico City.
    Fuentes-Gonzalez MF; Ordinola Navarro A; Carmona-Aguilera Z; Hernández-Jimenez CA; Benitez-Altamirano GM; Beltran-Ontiveros LD; Lopez-Vejar C; Ramirez-Hinojosa JP; Vera-Lastra O; Lopez Luis BA
    Fam Pract; 2022 May; 39(3):515-518. PubMed ID: 34910137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency.
    Hentschke-Lopes M; Botton MR; Borges P; Freitas M; Mancuso ACB; Matte U
    Cad Saude Publica; 2022; 38(7):e00001022. PubMed ID: 35894360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru].
    Castro NE; García DR; Rivera MT; Rondán-Guerrero P; García-Rojas F; Taype-Rondan A
    Rev Peru Med Exp Salud Publica; 2021; 38(4):608-614. PubMed ID: 35385014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect.
    Andreani J; Le Bideau M; Duflot I; Jardot P; Rolland C; Boxberger M; Wurtz N; Rolain JM; Colson P; La Scola B; Raoult D
    Microb Pathog; 2020 Aug; 145():104228. PubMed ID: 32344177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
    Fleury V
    Am J Epidemiol; 2020 Nov; 189(11):1227-1229. PubMed ID: 32685969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
    Rakedzon S; Neuberger A; Domb AJ; Petersiel N; Schwartz E
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33480414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
    Gautret P; Lagier JC; Parola P; Hoang VT; Meddeb L; Mailhe M; Doudier B; Courjon J; Giordanengo V; Vieira VE; Tissot Dupont H; Honoré S; Colson P; Chabrière E; La Scola B; Rolain JM; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2020 Jul; 56(1):105949. PubMed ID: 32205204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
    Lebeaux D; Revest M
    Travel Med Infect Dis; 2020; 36():101819. PubMed ID: 32629139
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine and azithromycin as a treatment of COVID-19.
    Fanin A; Calegari J; Beverina A; Tiraboschi S;
    Intern Emerg Med; 2020 Aug; 15(5):841-843. PubMed ID: 32474851
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
    Hor CP; Hussin N; Nalliah S; Ooi WT; Tang XY; Zachariah S; Jugindar Singh GPS; Abdul Rani R; Perumal K; Cheah WK
    J Infect; 2020 Aug; 81(2):e117-e119. PubMed ID: 32474031
    [No Abstract]   [Full Text] [Related]  

  • 20. Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic.
    Oliveira J E Silva L; Vidor MV; Zarpellon de Araújo V; Bellolio F
    Mayo Clin Proc; 2020 Sep; 95(9):1842-1844. PubMed ID: 32861327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.